
    the study was terminated for lack of efficacy after an interim analysis was performed
  
['atopic dermatitis']
['ly3375880', 'placebo']

        Inclusion Criteria:

          -  Participants must have diagnosis of AD >= 12 months according to the American Academy
             of Dermatology criteria.

          -  Participants must have moderate to severe AD at screening and randomization.

          -  Participants must have inadequate response to topical medications within 6 months of
             screening (or history of intolerance).

        Exclusion Criteria:

          -  Participants must not have concurrent treatment with topical or systemic treatments
             for AD.
      